Year: 2017

IRVINE, CA, and HERSTAL, BELGIUM – March 21, 2017 – MDxHealth SA (Euronext: MDXH.BR), today announced that it has signed a distribution agreement to make its SelectMDx™ for Prostate Cancer test available to Lab21 Clinical Laboratory’s urology clients in the United Kingdom. MDxH-Lab 21 agreement PR ENG

Novacyt – NOVAprep® Regulatory Update in US and China ENGLISH Paris, France and Cambridge, UK – 23rd February 2017 – Novacyt (ALTERNEXT: ALNOV), an international specialist in clinical diagnostics, today announces a regulatory update for its next generation NOVAprep® technology platform in the US and China.

Delivers consolidated sales growth of 25% NOVAprep® sales increase 24% Group reiterates positive outlook Novacyt revenues full year 2016 ENGLISH